UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein

JAMA neurology, 2015-08, Vol.72 (8), p.882

2015

Volltextzugriff (PDF)

Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia

Advances in pharmacology (1990), 2018-01, Vol.82, p.163-185

2018

Volltextzugriff (PDF)

Intact global cognitive and olfactory ability predicts lack of transition to dementia

Alzheimer's & dementia, 2020-02, Vol.16 (2), p.326-334

2020

Volltextzugriff (PDF)

Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy

Journal of Nuclear Medicine, 2012-02, Vol.53 (2), p.234-240

2012

Volltextzugriff (PDF)

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

BMJ open, 2020-02, Vol.10 (2), p.e032112-e032112

2020

Volltextzugriff (PDF)

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease

Neurobiology of aging, 2017-03, Vol.51, p.132-140

2017

Volltextzugriff (PDF)

Discerning the relationship between microglial activation and Alzheimer's disease

Brain (London, England : 1878), 2017-07, Vol.140 (7), p.1825-1828

Kreisl, William C

2017

Volltextzugriff (PDF)

PET imaging of neuroinflammation in neurological disorders

Lancet neurology, 2020-11, Vol.19 (11), p.940-950

2020

Volltextzugriff (PDF)

Neuroinflammation in psychiatric disorders: PET imaging and promising new targets

The Lancet. Psychiatry, 2020-12, Vol.7 (12), p.1064-1074

2020

Volltextzugriff (PDF)

Neuroinflammation in World Trade Center responders at midlife: A pilot study using [18F]-FEPPA PET imaging

Brain, behavior, & immunity. Health, 2021-10, Vol.16, p.100287-100287, Article 100287

2021

Volltextzugriff (PDF)

FDG-PET patterns associated with underlying pathology in corticobasal syndrome

Neurology, 2019-03, Vol.92 (10), p.e1121

2019

Volltextzugriff (PDF)

Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET

Alzheimer's & dementia : translational research & clinical interventions, 2023-01, Vol.9 (1), p.e12372-n/a

2023

Volltextzugriff (PDF)

Deep learning improves utility of tau PET in the study of Alzheimer's disease

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12264-n/a

2021

Volltextzugriff (PDF)

Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (6), p.2593-2598

2011

Volltextzugriff (PDF)

Non-invasive estimation of [11C]PBR28 binding potential

NeuroImage (Orlando, Fla.), 2018-04, Vol.169, p.278-285

2018

Volltextzugriff (PDF)

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

Brain (London, England : 1878), 2013-07, Vol.136 (Pt 7), p.2228-2238

2013

Volltextzugriff (PDF)

(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

Neurobiology of aging, 2016-08, Vol.44, p.53-61

2016

Volltextzugriff (PDF)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2020, Vol.12 (1), p.e12013-n/a

2020

Volltextzugriff (PDF)

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Journal of cerebral blood flow and metabolism, 2013-01, Vol.33 (1), p.53-58

2013

Volltextzugriff (PDF)

Mixed-affinity binding in humans with 18-kDa translocator protein ligands

Journal of Nuclear Medicine, 2011-01, Vol.52 (1), p.24-32

2011

Volltextzugriff (PDF)

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Movement disorders, 2022-01, Vol.37 (1), p.119-129

2022

Volltextzugriff (PDF)

Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease

Journal of Alzheimer's disease, 2021-01, Vol.80 (3), p.1051

2021

Volltextzugriff (PDF)

Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

NeuroImage (Orlando, Fla.), 2010-02, Vol.49 (4), p.2924-2932

2010

Volltextzugriff (PDF)

Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults

Neurobiology of aging, 2021-07, Vol.103, p.109-116

2021

Volltextzugriff (PDF)

Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11 C-PBR28

Journal of Nuclear Medicine, 2019-07, Vol.60 (7), p.978-984

2019

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein

Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia

Intact global cognitive and olfactory ability predicts lack of transition to dementia

Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer’s disease

Discerning the relationship between microglial activation and Alzheimer's disease

PET imaging of neuroinflammation in neurological disorders

Neuroinflammation in psychiatric disorders: PET imaging and promising new targets

Neuroinflammation in World Trade Center responders at midlife: A pilot study using [18F]-FEPPA PET imaging

FDG-PET patterns associated with underlying pathology in corticobasal syndrome

Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET

Deep learning improves utility of tau PET in the study of Alzheimer's disease

Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET

Non-invasive estimation of [11C]PBR28 binding potential

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease

(11)C-PBR28 binding to translocator protein increases with progression of Alzheimer's disease

Down syndrome: Distribution of brain amyloid in mild cognitive impairment

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Mixed-affinity binding in humans with 18-kDa translocator protein ligands

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease

Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults

Automatic Extraction of a Reference Region for the Noninvasive Quantification of Translocator Protein in Brain Using 11 C-PBR28

Suchergebnisse filtern